Literature DB >> 16713054

Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.

Jaime M Monti1, Héctor Jantos.   

Abstract

The effects of the 5-HT(2A/2C) receptor agonist DOI and of the selective 5-HT(2A) or 5-HT(2C) receptor antagonists EMD 281014 and SB-243213, respectively, on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings. The serotonergic ligands were microinjected directly into the dorsal raphe nucleus (DRN). Infusion of DOI (1.4-5.6 mmol) into the DRN induced a significant reduction of REM sleep (REMS) and of the number of REM periods. Following the microinjection of EMD 281014 (5.6 mmol) or SB-243213 (1.4-2.8 mmol) light sleep (LS) was slightly but significantly augmented. Pretreatment with EMD 281014 or SB-243213 antagonized the DOI-induced decrease of REMS. It is proposed that suppression of REMS after DOI microinjection into the DRN is related to the activation of GABAergic projection neurons that synapse cholinergic neurons in the laterodorsal and peduncunculopontine tegmental nuclei (LDT/PPT) involved in the promotion of REMS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713054     DOI: 10.1016/j.pnpbp.2006.02.013

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

2.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

3.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Authors:  Diána Kostyalik; Zita Kátai; Szilvia Vas; Dorottya Pap; Péter Petschner; Eszter Molnár; István Gyertyán; Lajos Kalmár; László Tóthfalusi; Gyorgy Bagdy
Journal:  Exp Brain Res       Date:  2014-01-07       Impact factor: 1.972

4.  High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles.

Authors:  Michael V Morabito; Randi J Ulbricht; Richard T O'Neil; David C Airey; Pengcheng Lu; Bing Zhang; Lily Wang; Ronald B Emeson
Journal:  Mol Pharmacol       Date:  2010-02-24       Impact factor: 4.436

Review 5.  Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.

Authors:  Tom Hildebrandt; Lauren Alfano; Michelle Tricamo; Donald W Pfaff
Journal:  Clin Psychol Rev       Date:  2010-05-31

Review 6.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

7.  Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.

Authors:  Steven C Leiser; Deborah Iglesias-Bregna; Ligia Westrich; Alan L Pehrson; Connie Sanchez
Journal:  J Psychopharmacol       Date:  2015-07-14       Impact factor: 4.153

8.  Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle.

Authors:  Emese Bogáthy; Noémi Papp; Laszló Tóthfalusi; Szilvia Vas; György Bagdy
Journal:  BMC Neurosci       Date:  2019-03-20       Impact factor: 3.288

Review 9.  Neurobiological and Hormonal Mechanisms Regulating Women's Sleep.

Authors:  Alanna Dorsey; Luis de Lecea; Kimberly J Jennings
Journal:  Front Neurosci       Date:  2021-01-14       Impact factor: 4.677

10.  Analysis of the effects of a tricyclic antidepressant on secondary sleep disturbance induced by chronic pain in a preclinical model.

Authors:  Hisakatsu Ito; Yoshinori Takemura; Yuta Aoki; Mizuki Hattori; Hideyo Horikawa; Mitsuaki Yamazaki
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.